Similarly, mutations in CCM2 and CCM3 also contribute to the pathogenesis of familial CMs by disrupting the normal functioning of endothelial cells and the structural integrity of blood vessels [12]. The gene discussed is CCM2; the disease is congenital myasthenic syndrome.